MedWatch

Chief scientific officer at Johnson & Johnson set to retire this year

As with Johnson & Johnson's CEO Alex Gorsky, the company's Chief Scientific Officer Paul Stoffels wants to step aside at the New Year, leaving the post for an as-of-yet unknown replacement.

Photo: Janssen/PR

Paul Stoffels, chief scientific officer at Johnson & Johnson, will exit his role at the company effective from the end of 2021, reports Bloomberg News.

The pharmaceutical giant has yet to find a replacement for Paul Stoffels, who has been with the company since 2002, spearheading the development of many treatments for HIV, Ebola and Zika virus, for example.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs